Published by Iain Gilbert on 8th May 2019
(Sharecast News) - Therapeutics outfit ReNeuron continued to trade in line with expectations throughout its recently wrapped up trading year, advancing both its human retinal progenitor cell therapy candidate and its CTX cell therapy candidate.
URL: http://www.digitallook.com/dl/news/story/29006639/...